Since clinical transcriptome data of patients with cHCC-ICC remains very limited, we were able only to verify the expression of Lamb1 in current published data; further larger-scale studies should be performed to assess its clinical value. This evidence concerns the gene LAMB1 and intrahepatic cholangiocarcinoma.